Survival after resection of pancreatic adenocarcinoma: Results from a single institution over three decades

Annals of Surgical Oncology

Volumn 19, Issue 1, 2012, Pages 169-175

  Winter, Jordan M ^a   Brennan, Murray F ^a   Tang, Laura H ^a   D'Angelica, Michael I ^a   Dematteo, Ronald P ^a   Fong, Yuman ^a   Klimstra, David S ^a   Jarnagin, William R ^a   Allen, Peter J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SURGERY; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MORTALITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FOLLOW-UP STUDIES; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84856462406     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1900-3     Document Type: Article

References (19)

1. MH Kalser SS Ellenberg 1985 Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection Arch Surg. 120 899 903 4015380 10.1001/archsurg.1985.01390320023003 1:STN:280:DyaL2M3ltFSnsQ%3D%3D
2. JP Neoptolemos DD Stocken H Friess, et al. 2004 A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med. 350 1200 1210 15028824 10.1056/NEJMoa032295 1:CAS:528:DC%2BD2cXit12rtr8%3D
3. H Oettle S Post P Neuhaus, et al. 2007 Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial JAMA. 297 267 277 17227978 10.1001/jama.297.3.267 1:CAS:528:DC%2BD2sXotVCmug%3D%3D
4. CB Begg LD Cramer WJ Hoskins MF Brennan 1998 Impact of hospital volume on operative mortality for major cancer surgery JAMA. 280 1747 1751 9842949 10.1001/jama.280.20.1747 1:STN:280:DyaK1M%2FlslSrsQ%3D%3D
5. JM Winter JL Cameron KA Campbell, et al. 2006 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience J Gastrointest Surg. 10 1199 1210 17114007 10.1016/j.gassur.2006.08.018
6. SR Grobmyer FM Pieracci PJ Allen MF Brennan DP Jaques 2007 Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system J Am Coll Surg. 204 356 364 17324768 10.1016/j.jamcollsurg.2006. 11.017
7. A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin. 59 225 249 19474385 10.3322/caac.20006
8. AG Thorson 2010 Progress in cancer care: a rational call to do better CA Cancer J Clin. 60 7 11 20097835 10.3322/caac.20047
9. TS Riall WH Nealon JS Goodwin, et al. 2006 Pancreatic cancer in the general population: improvements in survival over the last decade J Gastrointest Surg. 10 1212 1223 17114008 10.1016/j.gassur.2006.08.010
10. JP Simons SC Ng TP McDade Z Zhou CC Earle JF Tseng 2010 Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices Cancer. 116 1681 1690 20143432 10.1002/cncr.24918
11. JM Winter JL Cameron KD Lillemoe, et al. 2006 Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis Ann Surg. 243 673 680 16633003 10.1097/01.sla.0000216763. 27673.97
12. JH Balcom 4th DW Rattner AL Warshaw Y Chang C Fernandez-del Castillo 2001 Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization Arch Surg 136 391 398 11296108 10.1001/archsurg.136.4.391
13. T Kosuge T Kiuchi K Mukai T Kakizoe Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer (JSAP) 2006 A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer Jpn J Clin Oncol 36 159 165 16490736 10.1093/jjco/hyi234
14. HG Smeenk CH van Eijck WC Hop, et al. 2007 Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891 Ann Surg. 246 734 740 17968163 10.1097/SLA.0b013e318156eef3
15. S Boeck DP Ankerst V Heinemann 2007 The role of adjuvant chemotherapy for patients with resected pancreatic cancer: systematic review of randomized controlled trials and meta-analysis Oncology. 72 314 321 18187951 10.1159/000113054 1:CAS:528:DC%2BD1cXhs1yisLk%3D
16. NCCN Clinical practice guidelines in oncology. Pancreatic adenocarcinoma. http://www.nccn.org/professionals/physician-gls/PDF/pancreatic.pdf (2010).
17. KY Bilimoria DJ Bentrem CY Ko, et al. 2007 Multimodality therapy for pancreatic cancer in the U.S.: utilization, outcomes, and the effect of hospital volume Cancer. 110 1227 1234 17654662 10.1002/cncr.22916
18. KY Bilimoria DJ Bentrem JS Tomlinson, et al. 2007 Quality of pancreatic cancer care at Veterans Administration compared with non-Veterans Administration hospitals Am J Surg. 194 588 593 17936418 10.1016/j.amjsurg.2007.07.012
19. T Takada H Amano H Yasuda Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, et al. 2002 Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma Cancer 95 1685 1695 12365016 10.1002/cncr.10831